Cargando…
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
BACKGROUND: Systemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of SSc and a leading cause of death. MAIN BODY: All patients newly diagnosed with SSc should receive a comprehensive clinical evalu...
Autores principales: | Cottin, Vincent, Brown, Kevin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339436/ https://www.ncbi.nlm.nih.gov/pubmed/30658650 http://dx.doi.org/10.1186/s12931-019-0980-7 |
Ejemplares similares
-
Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
por: Fields, Aislin, et al.
Publicado: (2023) -
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
por: Khedoe, Padmini, et al.
Publicado: (2020) -
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
por: Kreuter, Michael, et al.
Publicado: (2022) -
Natural variability in the disease course of SSc-ILD: implications for treatment
por: Vonk, Madelon C., et al.
Publicado: (2021) -
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
por: Shenoy, Padmanabha D., et al.
Publicado: (2016)